Delivery Order SPE2DB24D2012-SPE2DB25FBWXK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of 36,000 units of Creon DR 100s capsules, valued at $6,150.38. This competitively awarded, firm fixed-price delivery order is set to be completed by July 30, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Creon DR 36,000 unit capsules in quantities of 100s, with a ceiling value of $12,946.57. This firm fixed-price delivery order, which is due for completion by July 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, and performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,117.97 to AmerisourceBergen Drug Corp for 24,000 unit capsules of Creon DR 100s. This competitively awarded contract, which carries no set-aside designation, was executed on August 13, 2025, with an ultimate completion date of August 14, 2025. The firm fixed price delivery order will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Creon DR 36,000 Unit Capsules in packages of 100 units. This competitive, non-set-aside contract is valued at $1,290.59 with firm fixed pricing and a completion date of August 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency awarded a delivery order valued at $1,101.10 to AmerisourceBergen Drug Corp on July 24, 2025, for 12,000 unit capsules of Creon (pancrelipase) in 100-count bottles. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, carrying an ultimate completion date of July 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply contract. This...
- The Defense Logistics Agency awarded a delivery order valued at $10,850.92 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules on August 27, 2025, with an ultimate completion date of August 28, 2025. This non-set-aside, firm fixed-price delivery order represents a direct procurement of pharmaceutical supplies to support military and federal healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $6,901.55 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply support to federal medical systems. The delivery will be performed at the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Creon DR 36,000 Unit Capsules in quantities of 100s, with a contract ceiling value of $2,424.24 and an ultimate completion date of September 12, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and is performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $9,025.18 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count bottles. This firm fixed price delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Creon (pancrelipase) capsules, 36,000 units in 100-count bottles, with a ceiling value of $2,424.24 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB25FBWXKDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $59,616.66 to AmerisourceBergen Drug Corp for the supply of Creon DR 36,000 Unit Capsules in quantities of 100s. This firm fixed-price delivery order, issued on September 8, 2025, represents a non-set-aside competitive award with an ultimate completion date of September 9, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp has demonstrated consistent capability to fulfill federal medical procurement requirements through open competition across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $59.6k | 9/8/25 |